, Tracking Stock Market Picks
Enter Symbol:
Cytrx Corporation (CYTR) [hlAlert]

down 90.84 %

Cytrx Corporation (CYTR) rated Buy

Posted on: Friday,  Oct 19, 2007  9:25 AM ET by Oppenheimer

Oppenheimer rated Buy Cytrx Corporation (NASDAQ: CYTR) on 10/19/2007, when the stock price was $25.34. Since
then, Cytrx Corporation has lost 90.84% as of 01/26/2016's recent price of $2.32.
If you would have followed this Oppenheimer's recommendation on CYTR, you would have lost 90.84% of your investment in 3021 days.

CYTRX CORP. is engaged in the development and commercialization of pharmaceutical related products and services including human therapeutics focused on high-value critical- care therapies.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/19/2007 9:25 AM Buy
25.34 42.00
as of 8/27/2015
1 Week down  -2.52 %
1 Month down  -42.43 %
3 Months down  -43.13 %
1 YTD down  -62.99 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy